Angiotensin converting enzyme in patients with sleep apnoea syndrome: plasma activity and gene polymorphisms

Barcelo A., Elorza M.A., Barbe F., Santos C., Mayoralas L.R., Agusti A.G.N.

Source: Eur Respir J 2001; 17: 728-732
Journal Issue: April
Disease area: Sleep and breathing disorders

Congress or journal article abstractPDF journal article, handout or slidesFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Barcelo A., Elorza M.A., Barbe F., Santos C., Mayoralas L.R., Agusti A.G.N.. Angiotensin converting enzyme in patients with sleep apnoea syndrome: plasma activity and gene polymorphisms. Eur Respir J 2001; 17: 728-732

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Angiotensin converting enzyme in patients with sleep apnoea syndrome: plasma activity and gene polymorphisms
Source: Eur Respir J 2001; 18: 1077
Year: 2001


Role of angiotensin receptors in the preclinical cardiovascular risk in obstructive sleep apnea patients
Source: International Congress 2017 – Best clinical practice for the management of chronic lung diseases
Year: 2017

Frequency of distribution of IL-1, IL-6 and TNFa gene polymorphism in patients with obstructive sleep apnea syndrome (OSAS)
Source: Annual Congress 2006 - Metabolic control in obstructive sleep apnoea
Year: 2006


The association of angiotensin-converting enzyme gene insertion/deletion polymorphisms with OSA: a meta-analysis
Source: Eur Respir J 2012; 40: 394-399
Year: 2012



Is obstructive sleep apnoea a risk factor for cardiovascular disease?
Source: Annual Congress 2005 - Cardiovascular disease and obstructive sleep apnoea: risks and remedy
Year: 2005

Metabolic disturbances in patients with obstructive sleep apnoea syndrome
Source: Eur Respir Rev 2007; 16: 196-202
Year: 2007



Sleep apnoea, hypertension and vascular disease: where are we now?
Source: Eur Respir Rev 2007; 16: 169-182
Year: 2007



Cardiovascular diseases are responsible for increased plasma NT-proBNP level in obstructive sleep apnoea (OSA) patients
Source: Annual Congress 2012 - Physiology, obesity and the downstream effects of OSA
Year: 2012


The phenotype and genotype of adult obstructive sleep apnoea/hypopnoea syndrome
Source: Eur Respir J 2009; 33: 646-655
Year: 2009



Cardiovascular risk, insulin resistance and metabolic syndrome in patients with obstructive sleep apnea
Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea
Year: 2007


Mortality in severe sleep apnoea/hypopnoea syndrome patients: impact of treatment
Source: Eur Respir J 2002; 20: 1511-1518
Year: 2002



Cystatin C and albuminuria as markers of kidney and cardiovascular diseases in obstructive sleep apnoea syndrome (OSAS)
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II
Year: 2012

Insulin resistance and insulin sensitivity in patients with sleep apnea syndrome
Source: Annual Congress 2005 - Metabolic control in OSA
Year: 2005


Combination between sleep apnoea and COPD: a synergistic risk for cardiovascular diseases?
Source: Sleep and Breathing Conference 2017
Year: 2017

5-lipoxygenase pathway: one of the mediators of early atherosclerosis in obstructive sleep apnea syndrome?
Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea
Year: 2007


Association of obstructive sleep apnea hypopnea syndrome with cardiovascular disease: a candidate gene association study
Source: Virtual Congress 2020 – Pathophysiology and treatment of obstructive sleep apnoea
Year: 2020


The risk of future cardiovascular diseases in the patients with OSAS is dependently or independently associated with obstructive sleep apnoea
Source: Eur Respir J 2001; 17: 573-574
Year: 2001


Genetic determinants of cardiovascular disease in patients with obstructive sleep apnea (OSA)
Source: International Congress 2015 – Ring of fire: inflammation and metabolism in sleep-disordered breathing
Year: 2015


JAG1 gene polymorphism is related to systemic blood pressure in patients with obstructive sleep apnoea
Source: International Congress 2016 – Cardiovascular and metabolic pathophysiology and outcomes of obstructive sleep apnoea
Year: 2016



Adiponectin is not a cardiovascular risk factor in otherwise healthy subjects with obstructive sleep apnea syndrome (OSAS)
Source: Annual Congress 2009 - Cardiovascular complications in obstructive sleep apnoea
Year: 2009